electroCore, Inc. (ECOR) Stock
Healthcare · Medical Devices · Member of Other US Stocks
electroCore, Inc. (ECOR) closed at USD 8.20 on 2026-10-14, a change of +68.7 % over the past year, with a market capitalization of USD 75.28M.
electroCore, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 8.20 |
| 2026-10-13 | 8.39 |
| 2026-10-12 | 9.28 |
| 2026-10-09 | 9.66 |
| 2026-10-08 | 9.51 |
| 2026-10-07 | 9.72 |
| 2026-10-06 | 9.92 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
electroCore, Inc. key figures
- Previous close
- USD 8.20 (2026-10-14)
- 1-year change
- +68.7 %
- Market cap
- USD 75.28M
- Enterprise value
- USD 74.8M
- P/E ratio (trailing)
- -5.15
- P/E ratio (forward)
- -15.18
- EPS (trailing)
- -1.62
- EPS (forward)
- -0.55
- PEG ratio
- n/a
- Price to book
- -26.94
- Revenue growth
- 28 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 3.69
- Employees
- 83
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About electroCore, Inc.
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for electroCore, Inc. and compare it with other stocks.
Analyze ECORAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell electroCore, Inc. shares.